AU4312393A - Use of water-soluble sucroses for the treatment and/or prevention of lesion or inflammation in the digestive tract - Google Patents

Use of water-soluble sucroses for the treatment and/or prevention of lesion or inflammation in the digestive tract

Info

Publication number
AU4312393A
AU4312393A AU43123/93A AU4312393A AU4312393A AU 4312393 A AU4312393 A AU 4312393A AU 43123/93 A AU43123/93 A AU 43123/93A AU 4312393 A AU4312393 A AU 4312393A AU 4312393 A AU4312393 A AU 4312393A
Authority
AU
Australia
Prior art keywords
sucroses
lesion
inflammation
prevention
soluble
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU43123/93A
Inventor
Niels Bukh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Buhk Meditec AS
Original Assignee
Buhk Meditec AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Buhk Meditec AS filed Critical Buhk Meditec AS
Publication of AU4312393A publication Critical patent/AU4312393A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU43123/93A 1992-06-30 1993-06-29 Use of water-soluble sucroses for the treatment and/or prevention of lesion or inflammation in the digestive tract Abandoned AU4312393A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK864/92 1992-06-30
DK92864A DK86492D0 (en) 1992-06-30 1992-06-30 PHARMACEUTICAL PRODUCT
PCT/DK1993/000214 WO1994000476A1 (en) 1992-06-30 1993-06-29 Use of water-soluble sucroses for the treatment and/or prevention of lesion or inflammation in the digestive tract

Publications (1)

Publication Number Publication Date
AU4312393A true AU4312393A (en) 1994-01-24

Family

ID=8098398

Family Applications (1)

Application Number Title Priority Date Filing Date
AU43123/93A Abandoned AU4312393A (en) 1992-06-30 1993-06-29 Use of water-soluble sucroses for the treatment and/or prevention of lesion or inflammation in the digestive tract

Country Status (3)

Country Link
AU (1) AU4312393A (en)
DK (1) DK86492D0 (en)
WO (1) WO1994000476A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5538954A (en) * 1994-06-24 1996-07-23 A/S Dumex (Dumex Ltd.) Salts of tetracyclines
US5783568A (en) * 1994-06-10 1998-07-21 Sugen, Inc. Methods for treating cancer and other cell proliferative diseases
FR2953522B1 (en) 2009-12-07 2012-03-09 Fabre Pierre Dermo Cosmetique SUCROSE ZINC OCTASULFATES, THEIR PREPARATION AND THEIR PHARMACEUTICAL AND COSMETIC APPLICATIONS
FR2956322A1 (en) * 2010-02-17 2011-08-19 Urgo Lab USE OF SYNTHETIC POLYSULFATE OLIGOSACCHARIDES AS DETERSION AGENTS OF A WOUND.
WO2012141773A1 (en) * 2011-04-13 2012-10-18 Carnegie Mellon University Methods and compositions for reducing shiga toxin induced toxicity in mammals
FR2975993B1 (en) 2011-05-31 2013-06-28 Fabre Pierre Dermo Cosmetique SUCROSES MAGNESIUM OCTASULFATES, THEIR PREPARATION AND THEIR PHARMACEUTICAL AND COSMETIC APPLICATIONS
FR2975994B1 (en) 2011-05-31 2015-03-06 Fabre Pierre Dermo Cosmetique SUCROSES OCTASULFATES OF CALCIUM, THEIR PREPARATION AND THEIR PHARMACEUTICAL AND COSMETIC APPLICATIONS
FR2991876B1 (en) 2012-06-13 2014-11-21 Vivacy Lab COMPOSITION, IN AQUEOUS MEDIUM, COMPRISING AT LEAST ONE HYALURONIC ACID AND AT LEAST ONE WATER-SOLUBLE SALT OF SUCROSE OCTASULFATE
FR2993781B1 (en) * 2012-07-30 2014-11-28 Fabre Pierre Dermo Cosmetique COMPOSITION OF A SUCROSE-OCTASULFATE AND EMOLLIENT
CN108530498A (en) * 2018-04-03 2018-09-14 安徽赛诺制药有限公司 A kind of new method eight sulphonic acid ester potassium of sucrose synthesis and purified

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3432489A (en) * 1965-11-05 1969-03-11 Chugai Pharmaceutical Co Ltd Disaccharide polysulfate aluminium compound and method
US4098995A (en) * 1976-07-12 1978-07-04 American Cyanamid Company Polygalactosido-sucrose poly(h-)sulfate salts
JPS5978116A (en) * 1982-10-27 1984-05-04 Chugai Pharmaceut Co Ltd Pharmaceutical preparation of sucralfate
DE3322078A1 (en) * 1983-06-20 1984-12-20 Merck Patent Gmbh, 6100 Darmstadt USE OF SUCRALFATE FOR CONTROLLING EMESIS AND / OR DIARRHOE
IT1203901B (en) * 1987-04-15 1989-02-23 Lisapharma Spa PHARMACEUTICAL COMPOSITIONS IN THE FORM OF STABLE SUCRALPHATE SUSPENSIONS FREE FROM SUSPENDING AGENTS
DK505488D0 (en) * 1987-12-21 1988-09-09 Bar Shalom Daniel MEDIUM AND USE OF SAME

Also Published As

Publication number Publication date
WO1994000476A1 (en) 1994-01-06
DK86492D0 (en) 1992-06-30

Similar Documents

Publication Publication Date Title
AU1063201A (en) Use of tgf beta and growth factors in the treatment and prevention of diseases of the intestinal mucosa
HUP9904221A3 (en) Use of cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia for producing pharmaceutical compositions
AU3581697A (en) Treatment and prevention of cancer by administration of derivatives of human chorionic gonadotropin
HUP9904361A3 (en) Use of isobutylgaba and its derivatives for the treatment of pain
AU3993795A (en) Peptide compounds for prevention and/or treatment of no-mediated diseases
AU7298796A (en) Forceps for the surgical introduction of catheters and the like
AU663833B2 (en) Surgical and/or clinical apparatus
IL112041A0 (en) Methods of inhibiting atrophy of the skin and vagina
AU1937395A (en) Pharmaceutical compositions containing alkylthioalkanoic acids or derivatives thereof and their use in the treatment of mycobacterial infections and as antiseptic
AU1575697A (en) Compositions and methods for the treatment and diagnosis of cancer
AU4312393A (en) Use of water-soluble sucroses for the treatment and/or prevention of lesion or inflammation in the digestive tract
AU5240700A (en) Naphthoquinone derivatives and their use in the treatment and control of tuberculosis
AU3099997A (en) The use of tcet in the prophylaxis and treatment of allergies
AU4210696A (en) Use of AICA riboside compounds for the treatment and prevention of tissue damage due to decreased blood flow
AU2734995A (en) Phytotherapeutic agent for treatment of skin lesions and morbid changes in the skin and method for its preparation
GB9321341D0 (en) Therapeutic compositions for use in the treatment of skin lesions and method of making same
HUP9904294A3 (en) Topiramate derivatives and their use for producing medicament useful in the treatment of neuropathic pain
AU4063197A (en) Antimicrobial medical devices and methods of production and use
IL105567A0 (en) X-ray contrast formulations and their use in the visualization of the gastrointestinal tract
AU2843397A (en) Agent for prophylaxis and treatment of disturbance of visual function
NO974486D0 (en) Low-dose "Ridogrel" formulations and their use in the treatment of intestinal inflammation
AU5201793A (en) Alpha, omega-diarylalkane derivatives, their preparation and their use in the treatment and prevention of circulatory diseases and psychosis
AU2705495A (en) Use of rooperol and hypoxoside and their derivatives in the treatment of inflammatory
AU7688998A (en) Use of metalloproteinase inhibitors in the treatment and prevention of pulmonaryemphysema
AU2115197A (en) Compositions and methods useful in the detection and/or treatment of cancerous conditions